Risk assessment and QbD based optimization of an Eprosartan mesylate nanosuspension: In-vitro characterization, PAMPA and in-vivo assessment - Shekhawat, P; Pokharkar, V (Int J Pharm, 2019)
10.1016/j.ijpharm.2019.06.006